| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.6M | +187.1% |
| Cost of Revenue | $11.6M | +200.3% |
| R&D Expense | $34.1M | +94.9% |
| SG&A Expense | $63.5M | +9.3% |
| Operating Income | -$177.0M | -118.6% |
| Pre-tax Income | -$161.0M | -97.6% |
| Income Tax | -$3.9M | — |
| Net Income | -$157.1M | -92.8% |
| EPS (Basic) | -$1.07 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.2M | -83.8% |
| Short-term Investments | $79.3M | — |
| Accounts Receivable | $1.9M | +136.8% |
| Inventory | $3.6M | +254.1% |
| Current Assets | $129.1M | -43.5% |
| Total Assets | $167.6M | -28.9% |
| Current Liabilities | $10.5M | +70.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.4M | -55.3% |
| Capital Expenditures | $1.5M | -68.0% |
| Investing Cash Flow | -$109.0M | -2226.0% |
| Financing Cash Flow | -$7.5M | -103.3% |
| Free Cash Flow | -$66.9M | -43.0% |
| -48.6% |
| EPS (Diluted) | -$1.07 | -48.6% |
| Total Liabilities |
| $23.2M |
| +6.0% |
| Stockholders' Equity | $144.4M | -32.5% |